Breaking News

iBio Expands Development and Mfg. Capacity

Enables the use iBio technologies to conduct development work from feasibility to Phase I

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

iBio CMO LLC, a subsidiary of iBio, Inc., a provider of plant-based biotechnology for developing and manufacturing biologics, has completed the expansion of product development capacity for the production of pharmaceutical proteins in hydroponically-grown green plants. This expansion enables the use iBio technologies to conduct concurrent product development work for clients in multiple product classes with transitions from lab-level feasibility and testing through cGMP production of active p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters